Daniel Soohoo

机构：Gilead Sciences (United States)

发表论文 8 篇 · 总被引 256 次 · h-index 6

代表论文

• Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists (2007 · Naunyn-Schmiedeberg s Archives of Pharmacology · 被引 82)
• Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells (2021 · Antimicrobial Agents and Chemotherapy · 被引 63)
• Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Na i), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties (2016 · Journal of Medicinal Chemistry · 被引 35)
• CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability (2004 · Bioorganic & Medicinal Chemistry Letters · 被引 33)
• New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties (2003 · Bioorganic & Medicinal Chemistry Letters · 被引 30)
• Novel inhibitors of fatty acid oxidation as potential metabolic modulators (2004 · Bioorganic & Medicinal Chemistry Letters · 被引 7)